Literature DB >> 2080326

Long-term results of stereotaxy in the treatment of essential tremor.

M Mohadjer1, H Goerke, E Milios, A Etou, F Mundinger.   

Abstract

In patients with severe tremor that is resistant to drug therapy, stereotactic coagulation can achieve a satisfactory and lasting reduction of the movement disorders. Very few long-term studies have been conducted following stereotactic operations. From 1964 to 1984, 104 patients with a diagnosis of essential tremor were operated on in the Division of Stereotaxy and Neuronuclear Medicine. After an average follow-up period of 8.6 years, 65 patients were examined. In 80%, the success of the stereotactic operation was still evident. Complete disappearance or substantial reduction of the tremor was determined in 69% and moderate improvement in 11.9% of the patients.

Entities:  

Mesh:

Year:  1990        PMID: 2080326     DOI: 10.1159/000100201

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  12 in total

1.  Essential Tremor.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Microstructural changes of the dentato-rubro-thalamic tract after transcranial MR guided focused ultrasound ablation of the posteroventral VIM in essential tremor.

Authors:  Jose A Pineda-Pardo; Raul Martínez-Fernández; Rafael Rodríguez-Rojas; Marta Del-Alamo; Frida Hernández; Guglielmo Foffani; Michele Dileone; Jorge U Máñez-Miró; Esther De Luis-Pastor; Lydia Vela; José A Obeso
Journal:  Hum Brain Mapp       Date:  2019-03-13       Impact factor: 5.038

3.  Applying Microelectrode Recordings in Neurosurgery.

Authors:  W S Anderson; J Winberry; C C Liu; C Shi; F A Lenz
Journal:  Contemp Neurosurg       Date:  2010-02-15

4.  Effects of human cerebellar thalamus disruption on adaptive control of reaching.

Authors:  Haiyin Chen; Sherwin E Hua; Maurice A Smith; Frederick A Lenz; Reza Shadmehr
Journal:  Cereb Cortex       Date:  2005-12-15       Impact factor: 5.357

Review 5.  Management of essential tremor.

Authors:  Theresa A Zesiewicz; Elmyra Encarnacion; Robert A Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 6.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 7.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

8.  Incisionless transcranial MR-guided focused ultrasound in essential tremor: cerebellothalamic tractotomy.

Authors:  Marc N Gallay; David Moser; Franziska Rossi; Payam Pourtehrani; Anouk E Magara; Milek Kowalski; Alexander Arnold; Daniel Jeanmonod
Journal:  J Ther Ultrasound       Date:  2016-02-13

Review 9.  Outcomes from stereotactic surgery for essential tremor.

Authors:  Robert Francis Dallapiazza; Darrin J Lee; Philippe De Vloo; Anton Fomenko; Clement Hamani; Mojgan Hodaie; Suneil K Kalia; Alfonso Fasano; Andres M Lozano
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-10-18       Impact factor: 10.154

10.  Direct visualization and characterization of the human zona incerta and surrounding structures.

Authors:  Jonathan C Lau; Yiming Xiao; Roy A M Haast; Greydon Gilmore; Kâmil Uludağ; Keith W MacDougall; Ravi S Menon; Andrew G Parrent; Terry M Peters; Ali R Khan
Journal:  Hum Brain Mapp       Date:  2020-07-17       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.